Clinical Trials in Corbeil-Essonnes, France
17 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
Eli Lilly and Company300 enrolled129 locationsNCT07222332
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Diabetes Mellitus, Type 1
Eli Lilly and Company150 enrolled108 locationsNCT07222137
Recruiting
Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
AstraZeneca11,300 enrolled917 locationsNCT06677060
Recruiting
Phase 2
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
Type 1 Diabetes Mellitus
Sanofi192 enrolled80 locationsNCT06111586
Recruiting
French Prospective Multicentric Study in Real World
Diabetes MellitusDiabetesType 1 Diabetes
Insulet Corporation304 enrolled24 locationsNCT07039942
Recruiting
Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML)
Acute Leukemia French Association5,000 enrolled30 locationsNCT04777916
Recruiting
UroCCR Database: French Research Network for Kidney Cancer -UroCCR
Kidney Cancer
University Hospital, Bordeaux30,000 enrolled58 locationsNCT03293563
Recruiting
Phase 3
Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome824 enrolled64 locationsNCT06918002
Recruiting
Phase 3
Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Colorectal Neoplasms
Federation Francophone de Cancerologie Digestive348 enrolled49 locationsNCT02885753
Recruiting
Not Applicable
EkiYou-Study-2 : A National Multicentric Trial of the EkiYou Application for Insulin Bolus Calculation
Diabetes Type 1Diabetes Type 2 on InsulinPancreatogenous Diabetes
DiappyMed154 enrolled16 locationsNCT06738849
Recruiting
BeAT1D: Benign Autoimmunity and Type 1 Diabetes
Type 1 Diabetes
Institut National de la Santé Et de la Recherche Médicale, France740 enrolled17 locationsNCT05139784
Recruiting
Phase 2Phase 3
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR
Acute Myeloid Leukemia (AML)
University Hospital, Angers3,100 enrolled56 locationsNCT02416388
Recruiting
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine
AML, Adult
French Innovative Leukemia Organisation230 enrolled42 locationsNCT06263387
Recruiting
Phase 3
Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over
Colonic Adenocarcinoma
Federation Francophone de Cancerologie Digestive774 enrolled140 locationsNCT02355379
Recruiting
Evaluation of Security and Efficacy of Medtrum Hybrid Closed Loop System
Type 1 Diabetes
Medtrum France160 enrolled17 locationsNCT06363916
Recruiting
Observational Study of the Use of DBLG1 System in Real Life
Type1diabetes
Diabeloop348 enrolled20 locationsNCT04749693
Recruiting
Phase 2
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Nice210 enrolled30 locationsNCT05260528